Loading organizations...
| Date | Company | Round | Lead Investor(s) | Co-Investor(s) |
|---|---|---|---|---|
| Oct 7, 2024 | Kailera Therapeutics | $400.0M Series A | Gotham Makker, Michael Gladstone, Atlas Venture, Bain Capital Life Sciences, RTW Investments | — |
| Jun 30, 2021 | ArriVent Biopharma | $150.0M Series A | Hillhouse Capital Group | Lilly Asia Ventures, Octagon Capital, OrbiMed, Zoo Capital |